Diagnostics News and Research

RSS
Life Technologies announces the Ion AmpliSeq Exome Certified Service Provider program

Life Technologies announces the Ion AmpliSeq Exome Certified Service Provider program

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Roche, Inovio Pharmaceuticals to develop DNA-based vaccines for prostate cancer and hepatitis B

Viewpoints: Navigators become 'major friction point;' conservative opponents of health law take tactics from civil rights conflict

Viewpoints: Navigators become 'major friction point;' conservative opponents of health law take tactics from civil rights conflict

New technology to diagnose influenza quickly

New technology to diagnose influenza quickly

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

FDA approves ABRAXANE chemotherapy drug for treatment of metastatic pancreatic cancer

FDA approves ABRAXANE chemotherapy drug for treatment of metastatic pancreatic cancer

Enzymatics buys Boulder-based ArcherDx

Enzymatics buys Boulder-based ArcherDx

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.